Shares of Global Cord Blood Co. (NYSE:CO – Get Free Report) dropped 4.9% on Wednesday . The company traded as low as $0.9510 and last traded at $0.9510. Approximately 50,070 shares traded hands during mid-day trading, a decline of 77% from the average session volume of 216,519 shares. The stock had previously closed at $1.00.
Global Cord Blood Stock Performance
The business’s 50 day simple moving average is $0.95 and its 200-day simple moving average is $0.96. The stock has a market capitalization of $115.60 million, a price-to-earnings ratio of 1.49 and a beta of 0.16.
Global Cord Blood Company Profile
Global Cord Blood Corporation (NYSE: CO) is a leading operator of umbilical cord blood banking services in the People’s Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.
In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.
Read More
- Five stocks we like better than Global Cord Blood
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.
